801283-95-4 Usage
General Description
Faldaprevir is a chemical compound that falls under the category of hepatitis C virus protease inhibitor. It is used in combination with other antiviral medications to treat chronic hepatitis C infection in adults. Faldaprevir works by targeting and inhibiting the protease enzyme of the hepatitis C virus, preventing the virus from replicating and spreading in the body. This helps to reduce the viral load in the blood and improve liver function. Faldaprevir is typically administered orally and is known to be effective in treating certain genotypes of hepatitis C virus. However, it may also have potential side effects and interactions with other medications, so it is important for patients to consult with their healthcare provider before starting treatment with Faldaprevir.
Check Digit Verification of cas no
The CAS Registry Mumber 801283-95-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,0,1,2,8 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 801283-95:
(8*8)+(7*0)+(6*1)+(5*2)+(4*8)+(3*3)+(2*9)+(1*5)=144
144 % 10 = 4
So 801283-95-4 is a valid CAS Registry Number.
801283-95-4Relevant articles and documents
Discovery of a potent and selective noncovalent linear inhibitor of the hepatitis C virus NS3 protease (BI 201335)
Llinàs-Brunet, Montse,Bailey, Murray D.,Goudreau, Nathalie,Bhardwaj, Punit K.,Bordeleau, Josée,B?s, Michael,Bousquet, Yves,Cordingley, Michael G.,Duan, Jiamin,Forgione, Pat,Garneau, Michel,Ghiro, Elise,Gorys, Vida,Goulet, Sylvie,Halmos, Ted,Kawai, Stephen H.,Naud, Julie,Poupart, Marc-André,White, Peter W.
experimental part, p. 6466 - 6476 (2010/11/04)
C-Terminal carboxylic acid containing inhibitors of the NS3 protease are reported. A novel series of linear tripeptide inhibitors that are very potent and selective against the NS3 protease are described. A substantial contribution to the potency of these
